Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Europe
Asia & Oceania
Middle East & Africa
EMEA Thought Leadership
SOLUTIONS
Research & Development
Real World Evidence
Commercialization
Safety & Regulatory Compliance
Technologies
LIFE SCIENCE SEGMENTS
Pharmaceutical Manufacturers
Emerging Biopharma
Consumer Health
MedTech
Generics
HEALTHCARE SEGMENTS
Information Partner Services
Financial Institutions
Public Health and Government
Patient Associations
Payers
Providers
THERAPEUTIC AREAS
Cardiovascular
Cell and Gene Therapy
Central Nervous System
GI & Hepatology
Infectious Diseases and Vaccines
Oncology
Pediatrics
Rare Diseases
View All
Impacting People's Lives
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Real World & Health Data Sets
Real World & Health Data Sets (desc)
Medical Affairs
Medical Affairs (desc)
Health Data Apps & AI
Health Data Apps & AI (desc)
Health Data Transformation
Health Data Transformation (desc)
Study Design
Study Design (desc)
Evidence Networks
Evidence Networks (desc)
Health Economics & Value
Health Economics & Value (desc)
Regulatory and Safety
Regulatory and Safety (desc)
Natural Language Processing
Natural Language Processing (desc)
Real World Evidence Library
Real World Evidence Library (desc)
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
COVID-19 & Commercialization
COVID-19 & Commercialization (desc)
Launch Strategy & Management
Launch Strategy & Management (desc)
Brand Strategy & Management
Brand Strategy & Management (desc)
Pricing & Market Access
Pricing & Market Access (desc)
Healthcare Professional Engagement
Healthcare Professional Engagement (desc)
Patient Engagement
Patient Engagement (desc)
Promotional Strategy
Promotional Strategy (desc)
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEW
Orchestrated Clinical Trials
Orchestrated Clinical Trials (desc)
Enterprise Information Management
Enterprise Information Management (desc)
Performance Management & Insights
Performance Management & Insights (desc)
Provider Reference Data Network
Provider Reference Data Network (desc)
Customer Engagement
Customer Engagement (desc)
Safety, Regulatory, Quality Compliance
Safety, Regulatory, Quality Compliance (desc)
Developer
Developer (desc)
Partner Programs
Partner Programs (desc)
Technology Insights
Technology Insights (desc)
The IQVIA difference
CLINICAL PRODUCTS
Planning Suite
Site Suite
Patient Engagement Suite
Trial Management Suite
Clinical Data Analytics Suite
COMMERCIAL PRODUCTS
Information Management
Launch Strategy & Management
Performance Management & Insights
Brand Strategy & Management
Customer Engagement
Pricing & Market Access
COMPLIANCE, SAFETY, REG PRODUCTS
Commercial Compliance
Regulatory Compliance
Quality Compliance
Safety & Pharmacovigilance
REAL WORLD PRODUCTS
Data Profiling
Patient Profiling
HCP Profiling
Market Profiling
Health Data Transformation
Natural Language Processing
CASE STUDY
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Americas
Europe
Asia & Oceania
Middle East & Africa
EMEA Thought Leadership
Oncology Expertise for Development Success
Hear from IQVIA oncology experts on the topics, trends and scientific developments that are relevant to your clinical development program.
Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
Latest article published on Nature Reviews Drug Discovery, providing an update to previous PD-1/PD-L1 analyses.
Biomarkers and targeted therapy
Article
Trends in Clinical Development for PD-1/PD-L1 Inhibitors
Article reprint from Nature Reviews Drug Discovery
Blog
A closer look at PD-1/PD-L1 inhibitors
By:
Jeffrey P Hodge
How trial innovation is pushing treatment boundaries for rare and hard-to-treat cancers
Publication
Combinations take centre stage in PD1/PDL1 inhibitor clinical trials
Reprint from Nature Reviews Drug Discovery
Infographic
Biomarker Testing In Oncology
Prev
Next
CELL AND GENE THERAPY
Institute Reports
Global Oncology Trends 2023
Publication
The clinical pipeline for cancer cell therapies
Prev
Next
Novel Trial Design in Oncology
Insight Briefs
Navigating the Complex Oncology Landscape
white paper
Decentralized Oncology Trials
White Paper
A Different Route to Faster Approvals
Prev
Next
IMMUNO-ONCOLOGY
White Paper
Excellence in Immuno-Oncology Clinical Trials
White Paper
Immuno-Oncology Clinical Development
White Paper
Deal trends in immuno-oncology
Prev
Next
Global Oncology Trends 2022
This annual trend report on Global Oncology from the IQVIA Institute examines those novel medicines and the clusters of research which promise a continuing sequence of breakthroughs in the decade to come. The report explores the impact of COVID-19 disruptions and the longer-term trends in the use of cancer medicines as well as the drivers of spending globally, in key geographies, by tumor type, and for specific types of oncology drugs.
Advancing Pediatric Cancer Research
Impact and Implications of the RACE for Children Act.
Evolving Oncology Endpoints
This report examines trends in new and evolving oncology endpoints being studied in clinical trials.